Oxford Nanopore and DZD Partnership
November 14 2023
Collaboration aimed at optimizing a same-day identification diagnostic system for clinical use.
Read More
DZD Names Jeff Mirviss Chair of Board of Directors
October 24 2023
"Jeff has been an important advisor, investor and supporter of DZD... the company has benefitted greatly from his involvement and counsel."
Read More
Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek
October 10 2023
Day Zero Lab Services launches new rapid high resolution organism ID service, epiXact® ID
Read More
DZD Welcomes Dr. Patricia Simner to Advisory Board
October 4 2023
We are honored to have Dr. Simner join Day Zero Diagnostics’ Clinical Advisory Board
Read More
DZD Announces Completion of $16M Financing Round
September 20 2023
This latest financing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding.
Read More
DZD Awarded SBIR Grant for Development of Microbiome Diagnostics
August 29 2023
This award funds DZD's development of epiXact®FMT, a pharmacovigilance assay to enhance safety and efficacy in fecal microbiota transplant (FMT) clinical trials.
Read More